Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-07

FDA Approved: LIFITEGRAST — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved Aurobindo Pharma Limited's original ANDA for Lifitegrast, a generic treatment for dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lifitegrast (lifitegrast)

Snippet

ORIG AP for LIFITEGRAST (LIFITEGRAST)